Kim Stratton

Kim Stratton currently works at Centogene GmbH, as Chief Executive Officer from 2022, Recordati SpA, as Non-Executive Director from 2021, European Federation of Pharmaceutical Industries & Assns, as Director, Vifor Pharma Management AG, as Director, and Novonesis (Novozymes A, as Independent Director from 2024.
Ms. Stratton also formerly worked at Strategic Partners A, as Chief Executive Officer from 2019 to 2020, Centogene NV, as Chief Executive Officer & Managing Director from 2021 to 2023, Corden Pharma Fribourg SA, as Independent Director, Novozymes A, as Independent Director from 2017 to 2023, Bristol Myers Squibb Co., as Head-Marketing, AstraZeneca PLC, as Head-United Kingdom Respiratory Business, Novartis AG, as Head-Group Country Management & External Affairs from 2010 to 2013, GlaxoSmithKline Investments Pty Ltd., as Sales Representative, Novartis UK Ltd., as Chief Operating Officer, and Shire International GmbH, as Head-International Commercial.